ATRA Live signaler | Maksimer profitt med Getagraph.com

KJøP 107602 min ago

@ $0.771

Utstedt: 14 feb 2024 @ 19:55

Avkastning: -10.52%

Forrige signal: feb 13 - 21:34

Forrige signal: Selg

Avkastning: -0.05 %

Live Chart Being Loaded With Signals

Commentary (26 apr 2024 @ 22:00):

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States...

Stats
Dagens volum	526 741
Gjennomsnittsvolum	2.69M
Markedsverdi	82.36M
EPS	$0 ( 2024-03-27 )
Neste inntjeningsdato	( $-0.370 ) 2024-05-13
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.260
ATR14	$0.00200 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-31	Fust Matthew K	Buy	150 000	Common Stock
2024-03-31	Heiden William K	Buy	150 000	Common Stock
2024-03-31	Roncarolo Maria Grazia	Buy	150 000	Common Stock
2024-03-31	Gallagher Carol Giltner	Buy	150 000	Common Stock
2024-03-31	Mallik Ameet	Buy	150 000	Common Stock

INSIDER POWER
70.32
Last 100 transactions
Buy: 8 350 944 \| Sell: 2 074 393

Volum Korrelasjon

Lang: -0.13 (neutral)

Kort: 0.82 (strong)

Signal:(52.538) Same movement expected

Atara Biotherapeutics Inc Korrelasjon

10 Mest positive korrelasjoner
SRTS	0.965
CDXS	0.964
LGHL	0.959
ZD	0.957
ZYNE	0.952
RKDA	0.95
ATER	0.949
HNNA	0.948
NMTR	0.948
DYNT	0.946

10 Mest negative korrelasjoner
MCAA	-0.951
MSDA	-0.949
CITE	-0.945
DHAC	-0.944
AHRN	-0.942
LEGA	-0.942
ADAL	-0.942
FTAA	-0.94
PFTA	-0.939
ZING	-0.939

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Atara Biotherapeutics Inc Korrelasjon - Valuta/Råvare

-0.60
( weak negative )

-0.57
( weak negative )

0.00
( neutral )

0.85
( strong )

Atara Biotherapeutics Inc Økonomi

Annual	2023
Omsetning:	$8.57M
Bruttogevinst:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2023
Omsetning:	$8.57M
Bruttogevinst:	$-313 000 (-3.65 %)
EPS:	$-2.61

FY	2022
Omsetning:	$63.57M
Bruttogevinst:	$49.01M (77.08 %)
EPS:	$-2.24

FY	2021
Omsetning:	$20.34M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-3.63

Financial Reports:

No articles found.

Atara Biotherapeutics Inc

Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company is also developing next-generation CAR T immunotherapies for patients with hematologic malignancies and solid tumors, including ATA2271 and ATA3271 for mesothelin; and ATA2431 and ATA3219 for B-cell malignancies, as well as ATA188 for the treatment of multiple sclerosis. In addition, it develops ATA368 program for patients with human papillomavirus associated cancers. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center, as well as Bayer AG for mesothelin-targeted CAR T-cell therapies for solid tumors. The company was incorporated in 2012 and is headquartered in South San Francisco, California.